McLean, Va. – Oct. 7, 2014 – RxAnte, LLC, the leading platform for improving medication use through predictive analytics and targeted clinical programs, today announced Amie Joyce, MPH, as Vice President of Account Management. Ms. Joyce will also join the Company’s leadership team.

“RxAnte is in the midst of significant growth, and it is important to continue to meet the evolving needs of our clients by providing data-driven insights and innovations that improve the use of prescription medications for the patients they serve,” said Aaron McKethan, PhD, President of RxAnte. “Amie is an excellent addition to our Company and our leadership team. With her assistance, RxAnte will continue to achieve our corporate mission to make a difference for patients, clients, and partners across the healthcare landscape.”

Ms. Joyce adds, “I am thrilled to join RxAnte and look forward to meeting the needs of RxAnte’s growing list of partners by delivering excellent client service and innovative solutions.”

Ms. Joyce has 20 years of experience in healthcare analytics, account management, and consulting with health plans, PBMs, pharmaceutical companies, and others in the healthcare industry. Prior to joining RxAnte, she led the account management function within the Payer and Provider division of IMS Health. She also was responsible for the management of key pharmaceutical accounts and has designed and conducted numerous health-economic and epidemiologic evaluations while at PharMetrics, Inc. (acquired by IMS). Prior to that, Ms. Joyce managed a research analytics group for Merck-Medco (now Express Scripts), which was responsible for evaluations of disease management and intervention programs for both internal and external audiences and the pharmaceutical industry. Ms. Joyce holds an MPH in epidemiology and biostatistics from Yale University School of Medicine, and a BA in mathematics from Boston College.

About RxAnte
RxAnte is the leading platform for improving medication use and drug therapy outcomes through predictive analytics and targeted clinical programs. Its innovative analytics platform is transforming how organizations work with healthcare professionals, care management intervention providers, and patients to promote the safe and effective use of prescription medications. Created by medication adherence, health IT, and advanced analytics experts, the “RxAnte System” is a patent-pending platform that includes predictive and decision analytics, advanced evaluation methods, and an innovative platform for provider engagement. Learn more at rxante.test or follow us on Twitter.